Grape King Bio Ltd. · TWSE:1707
Grape King Bio — SinoPac Securities' Conference on Air 2026
27 slides from Grape King Bio's conference presentation, Mar 19, 2026
Slide 1: Grape King Bio (1707 TT) Investor Presentation
Grape King Bio (1707 TT) Investor Presentation Mar 19, 2026
Slide 2: Company Milestone
Company Milestone Uni-President (1216 TT) became a shareholder and Taiepi Grape King Sales strategic partner through a Pro-Partner ranked No. 38 Grape King Bio-Tech among worldwide direct Grape King Longtan Pro-Partner was HQ was established private placement HQ in Pingzhen selling company Plant in
Slide 3: 2025 Results
iG! fal selt FIX 2025 Results
Slide 4: Company Overview: Three core business units
Company Overview: Three core business units 4 1. Taiwan Grape King (Parent Co) 2025 Revenue 2025 Net Profit Taiwan Taiwan own brand & global OEM/ODM Grape King Focus of all key ingredient design, formulation, and production for UVACO the whole Group. 10% 13% -2% 22% Shanghai 2. UVACO (60%-own) Grape
Slide 5: 2025 Revenue Declined by 8.1%
2025 Revenue Declined by 8.1% 5 Revenue NT$mn 12,000 11,160 -8.1% 10,251 10,000 8,835 -10.9% 7,876 8,000 6,000 4,000 +16.2% -12.3% 2,000 1,179 1,146 1,370 1,005 0 2024 2025 Taiwan Grape King Shanghai Grape King UVACO Consolidated 2025 Revenue declined by NT$908mn（UVACO –NT$959mn, Shanghai Grape King
Slide 6: 2025 EPS
2025 EPS 6 Cumulative EPS (NT$) 1Q 1Q-2Q 1Q-3Q 1Q-4Q 2022 1.59 4.19 6.65 9.84 2023 1.89 4.17 6.65 9.81 2024 1.74 3.95 6.76 9.78 2025 1.40 3.22 5.22 8.22
Slide 7: Income Statement
Income Statement 7 (NT$ mn) 2021 2022 2023 2024 2025 YoY (%) Revenue 9,798 10,391 10,635 11,160 10,252 -8.1% Gross Profit 7,855 8,481 8,534 8,658 7,698 -11.1% Operating Expenses (5,543) (5,929) (6,037) (6,158) (5,556) -9.8% Operating Profit 2,312 2,552 2,497 2,500 2,142 -14.3% Non Operating Income/(
Slide 8: Dividend Payout and Capex
Dividend Payout and Capex 8 (NT$ mn) 2021 2022 2023 2024 2025 2026 Net Profit 1,300 1,457 1,453 1,448 1,218 - Cash Dividend 904 1,022 1,022 1,022 889 - Cash DPS (NT$) 6.1 6.9 6.9 6.9 6.0 - Payout Ratio 69.2% 70.1% 70.3% 70.6% 73.0% 70.0% (*planned) EPS (NT$) 8.81 (*1) 9.84 9.81 9.78 8.22 Capex 1,481
Slide 9: Balance Sheet
Balance Sheet 9 (NT$mn) 2020 2021 2022 2023 2024 2025 Total Assets 13,104 14,061 15,053 15,512 15,324 15,738 Cash 2,927 3,635 4,673 4,819 4,343 4,165 AR &NR 202 301 270 291 305 337 Inventories 689 719 688 688 754 829 Fixed Assets 7,308 7,208 7,360 7,539 7,699 7,841 Total Liabilities 5,126 3,632 3,91
Slide 10: 1. Taiwan Grape King
1. Taiwan Grape King dates
Slide 11: Grape King Taiwan – Business Overview
Grape King Taiwan – Business Overview NT$mn Grape King Taiwan Sales (Own brand + ODM/OEM) 1,500 11 +16% YoY 1,370 +13% YoY 1,247 -5% 1,300 +21% YoY 1,179 YoY 1,104 1,100 914 900 700 2021 2022 2023 2024 2025 2026 Jan-Feb revenue NT$269mn, grew by NT$56mn（↑26.0% YoY）
Slide 12: Grape King Taiwan – Own Brand Business Overview
Grape King Taiwan – Own Brand Business Overview 12 NT$mn Grape King Taiwan Own brand Sales 900 +14% 840 850 YoY -15% 800 YoY +12% 737 750 YoY 716 -8% YoY 700 658 657 650 600 550 500 2021 2022 2023 2024 2025 2026 Jan-Feb revenue NT$108mn, grew by NT$5mn（↑4.2% YoY）
Slide 13: Grape King Taiwan – OEM/ODM Business Overview
Grape King Taiwan – OEM/ODM Business Overview 13 NT$mn Grape King Taiwan ODM/OEM Sales 800 +54% YoY 713 700 600 +14% YoY 500 +11% 463 YoY +44% 407 400 YoY 367 300 255 200 2021 2022 2023 2024 2025 2026 Jan-Feb revenue NT$161mn, grew by NT$51mn（↑46.8% YoY）
Slide 14: Grape King Taiwan – 2025Q1-Q3 OEM/ODM Performance
Grape King Taiwan – 2025Q1-Q3 OEM/ODM Performance 14 2024 2025 54% 2025 PIC/S, 8% Raw Materials PIC/S, P 25% 15% Customer, P 34% Customer, Raw 24% 463 M 713 M materials 17% Finished Goods, Finished Goods, 43% 34% *PIC/S halted production in the first half of 2024 due to material shortages, but shipm
Slide 15: Grape King Reishi Botanical Drug – FDA-Approved for Phase II Clinical Trial
Grape King Reishi Botanical Drug – FDA-Approved for Phase II Clinical Trial 15 • Reishi (Antrodia camphorata), known as Taiwan’s “Ruby of the Forest,” is recognized for its protective and anti-fatigue properties. • Grape King has over 20 years of Reishi R&D, holding multiple efficacy studies and pat
Slide 16: 2. UVACO
iT <q 2. UWVACO
Slide 17: UVACO Overview – Key Numbers
UVACO Overview – Key Numbers 17 2 Taiwan’s Second Largest 2 Taiwan’s Second Largest Local Direct Sales Company Direct Sales Company (Based on Revenue Rankings) (2024 Market Share: 9.92%) 52 Products, including health supplements, skincare solutions & oral care essentials
Slide 18: UVACO Revenue
UVACO Revenue 18 2025 -10.9% YoY 2026 Jan-Feb grew NT$7mn (up 0.7% YoY) 2024年 -15.0% +1.7% -3.4% -7.8% -13.9% -4.4% -10.1% +2.8% -41.8% +25.9% +0.4% -36.8% 2025年 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec (NT$mn) Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan-Dec 2024 573.2 449.7 759.
Slide 19: Update on UVACO Skincare Products
Update on UVACO Skincare Products 19 Unit：NT$mn 500 +26% 472 7.0% 450 YoY +7% 6.0% 400 YoY 375 350 6.0% 350 5.0% 300 4.0% 250 4.1% 4.2% 3.0% 200 Revenue Contribution % to UVACO 150 2.0% 100 1.0% 50 6 SKUs 6 SKUs 11 SKUs 0 0.0% 2023 2024 2025 2026 Jan-Feb Revenue NT$84mn, accounts 8.8% of UVACO reven
Slide 20: Pro-Partner rebranded to UVACO for Global Expansion
Pro-Partner rebranded to UVACO for Global Expansion 20 • Pro-Partner has now been rebranded to “UVACO”, as we initiate a brand revamp while simultaneously advancing our global operational footprint. • In 2026, our operations center will be established in Kuala Lumpur, Malaysia, serving as a key hub
Slide 21: 3. Shanghai Grape King
21 3. Shanghai Grape King
Slide 22: Shanghai Grape King GMP
Shanghai Grape King Plant Size Covers area of 170 hectares GMP Plant of 12,500 sqm GMP 10k-level qualified manufacturing site manufacturing plant (Compliant with health (Liquid filling food product and 10k-level) safety standards)
Slide 23: Integrated OEM Service Platform
Integrated OEM Service Platform ODM/OEM One-stop service R&D Formulation Design Package Design Production Regulatory Support Training Solutions Logistics Declaration Support
Slide 24: Customers of Shanghai Grape King
Customers of Shanghai Grape King 24
Slide 25: Slide 25
Slide 26: Outlook
Outlook 26 • UVACO ： • Direct Selling model that helps our member reach global sales. • 20 products to be launched within the next 2 years via the UVACO ASEAN network. • Topical Products: Transitioning from “Personal Care” to a “Comprehensive Lifestyle” Brand. • Proprietary Raw Material： • Enter Glo
Slide 27: Thank You!
Thank You! For more information, please visit our website： www.grapeking.com.tw 27
Grape King Bio — SinoPac Securities' Conference on Air 2026 on 6ix